首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1698361

輸液幫浦市場：2025-2030 年預測

Infusion Pump Market - Forecasts from 2025 to 2030

出版日期: 2025年02月24日 | 出版商:

Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

輸液幫浦市場預計將從 2025 年的 111.01 億美元成長到 2030 年的 144.58 億美元，複合年成長率為 5.43%

輸液幫浦在醫療保健中發揮著至關重要的作用，可以有效地向患者體內輸送控制量的藥物、營養物質或液體。這些設備廣泛應用於醫院、療養院甚至家庭等各種環境，與手動管理相比具有許多優勢。輸液幫浦由經過訓練的使用者操作，配有使用者友善的軟體介面，可精確編程輸液速率和持續時間。此功能允許以自動間隔進行小量輸液，從而提高治療的準確性和可靠性。

市場趨勢：

非傳染性疾病（NCD）負擔加重：世界衛生組織（WHO）對非傳染性疾病（NCD）日益成長的影響表示擔憂，並預測，如果目前的趨勢持續下去，到2050年，心血管疾病、癌症、糖尿病和呼吸系統疾病等慢性疾病將佔每年9,000萬死亡人數的86%。這些疾病的主要風險因素包括吸菸、接觸二手菸、營養不良（水果和蔬菜攝取量低、鈉和飽和脂肪攝取量高）、缺乏運動和過量飲酒。為了應對日益嚴重的慢性病流行，世界各國政府都在增加醫療保健支出，以解決導致非傳染性疾病的複雜因素。
人口老化推動醫療保健需求：全球人口正在經歷重大的人口結構變化，亞太地區（APAC）老齡人口顯著增加。 2016年，亞太地區約有12.4%的人口年齡在60歲及以上，預計到2050年這一數字將超過25%（13億人）。這種變化在東亞和北亞地區將特別明顯，例如日本和韓國，預計到2050年，這些地區超過三分之一的人口年齡將在60歲以上。同樣，在歐盟（EU-27），65歲及以上人口預計將從2023年的9,140萬增加到2050年的1.298億，其中75-84歲年齡層增加56.1%，65-74歲年齡層增加16.6%。美國正經歷重大的人口結構轉變，老年人口從2010年到2020年成長了38.6%，從4,030萬增加到5,580萬。
北美在輸液幫浦市場佔據主導地位：預計北美將佔據輸液幫浦市場的大部分佔有率。根據美國醫院協會的數據，美國醫院數量將從 2022 年的 6,093 家增加到 2024 年的 6,120 家，住院病患人數將從 2022 年的 33,356,853 人增加到 2024 年的 34,113,745 人。

報告中介紹的主要企業包括百特國際公司 (Baxter International Inc.)、碧迪公司 (Becton, Dickinson and Company，簡稱 BD)、B. Braun Melsungen AG、強生公司 (Johnson &Johnson)、美敦力公司 (Medtronic plc.)、尼普洛公司 (Niprorum Corporation)、Biomedix、EICU Medical.

本報告的主要優點

深刻分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透。
市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
可行的建議：利用洞察力進行策略決策，在動態環境中開闢新的業務流和收益。
適合廣泛的使用者：對於新興企業、研究機構、顧問公司、中小企業和大型企業來說都是有益且具有成本效益的。

它有什麼用途？

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

2022 年至 2024 年的歷史資料和 2025 年至 2030 年的預測資料
成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
競爭定位、策略和市場佔有率分析
收益成長和預測分析（包括國家在內的細分市場和地區）
公司概況（特別是財務資訊和關鍵發展）。

輸液幫浦市場細分：

輸液幫浦市場細分為：

胰島素幫浦
PCA泵浦
腸內泵
其他

輸液幫浦市場按機制細分：

注射式幫浦是最大的細分市場之一。本報告按機制對輸液幫浦市場進行細分，如下：

注射式幫浦
彈性體泵
蠕動幫浦
多通道泵浦
智慧泵浦

輸液幫浦市場按應用細分：

該報告按應用對輸液泵市場進行了細分，具體如下：

化療
消化道
糖尿病
疼痛管理
血
其他

輸液幫浦市場按地區細分：

本研究也提供了針對輸液幫浦市場的特定國家的預測和分析，將其分為以下區域：

北美（美國、加拿大、墨西哥）
南美洲（巴西、阿根廷和其他南美洲地區）
歐洲（德國、英國、法國、西班牙和其他歐洲國家地區）
中東和非洲（沙烏地阿拉伯、阿拉伯聯合大公國和其他中東和非洲地區）
亞太地區（中國、日本、印度、韓國、泰國、印尼、亞洲其他地區）

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
南美洲
- 巴西
- 阿根廷
- 其他
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 其他
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 其他
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 台灣
- 泰國
- 印尼
- 其他

第9章競爭格局及分析

主要企業和策略分析
市場佔有率分析
合併、收購、協議和合作
競爭儀錶板

第10章公司簡介

Baxter International Inc.
Becton, Dickinson and Company（BD）
B. Braun Melsungen AG.
Johnson & Johnson
Medtronic plc.
Nipro Corporation
Biomedix Medical
Eitan Medical
Smiths Medical（ICU Medical）
Terumo Corporation

第11章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要利益
調查方法
簡稱

簡介目錄

Product Code: KSI061610455

The infusion pump market is expected to grow at a CAGR of 5.43% from US$11.101 billion in 2025 to US$14.458 billion in 2030

Infusion pumps play a crucial role in the medical field, efficiently delivering controlled amounts of fluids, such as medications and nutrients, into patients' bodies. Widely utilized in diverse settings like hospitals, nursing homes, and even at home, these devices offer numerous advantages over manual administration. Operated by trained users, infusion pumps work with a user-friendly software interface that allows precise programming of fluid delivery rates and durations. This capability enables the delivery of fluids in small volumes and at automated intervals, enhancing accuracy and reliability in medical treatments.

Market Trends:

Rising Burden of Non-Communicable Diseases (NCDs): The World Health Organization (WHO) has raised concerns about the increasing impact of non-communicable diseases (NCDs), projecting that chronic conditions such as cardiovascular diseases, cancer, diabetes, and respiratory illnesses could account for 86% of the 90 million annual deaths by 2050 if current trends continue. Key risk factors contributing to these diseases include tobacco use, exposure to secondhand smoke, poor nutrition (low fruit and vegetable intake, high sodium and saturated fat consumption), physical inactivity, and excessive alcohol consumption. In response to the growing prevalence of chronic diseases, governments worldwide are increasing healthcare spending to address the complex factors driving NCDs.
Aging Population Driving Healthcare Demand: The global population is undergoing significant demographic changes, with the Asia-Pacific (APAC) region seeing a notable rise in its elderly population. In 2016, around 12.4% of the APAC population was aged 60 or older, a figure expected to exceed 25% (1.3 billion people) by 2050. This shift is particularly pronounced in East and North Asia, including countries like Japan and South Korea, where over a third of the population will be aged 60 or older by 2050. Similarly, in the European Union (EU-27), the population aged 65 or older is projected to grow from 91.4 million in 2023 to 129.8 million by 2050, with the 75-84 age group increasing by 56.1% and the 65-74 age group by 16.6%. In the United States, the elderly population grew by 38.6% from 2010 to 2020, rising from 40.3 million to 55.8 million, marking a significant demographic shift.
North America's Dominance in the Infusion Pump Market: North America is expected to hold a substantial share of the infusion pump market. According to the American Hospital Association, the number of U.S. hospitals increased from 6,093 in 2022 to 6,120 in 2024, with hospital admissions reaching 34,113,745 in 2024 (up from 33,356,853 in 2022).

Some of the major players covered in this report include Baxter International Inc., Becton, Dickinson and Company (BD), B. Braun Melsungen AG., Johnson & Johnson, Medtronic plc., Nipro Corporation, Biomedix Medical, Eitan Medical, Smiths Medical (ICU Medical), and Terumo Corporation among others.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Infusion Pump Market Segmentation:

The Infusion Pump Market is analysed By Type into the following:

Insulin Pump
PCA Pump
Enteral Pump
Others

Infusion Pump Market Segmentation By Mechanism:

Syringe pump is one of the largest market segments. The report analysed the Infusion Pump Market into different mechanism as below:

Syringe Pump
Elastomeric Pump
Peristaltic Pump
Multi-channel Pump
Smart Pump

Infusion Pump Market Segmentation By Application:

The report analysed the infusion pump market across application as following:

Chemotherapy
Gastroenterology
Diabetes
Pain Management
Hematology
Others

Infusion Pump Market Segmentation By Region:

The study also analysed the Infusion Pump Market into the following regions, with country level forecasts and analysis as below:

North America (US, Canada and Mexico)
South America (Brazil, Argentina, and Rest of South America)
Europe (Germany, UK, France, Spain and Rest of Europe)
Middle East and Africa (Saudi Arabia, UAE and Rest of Middle East and Africa)
Asia Pacific (China, Japan, India, South Korea, Thailand, Indonesia, and Others)

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. INFUSION PUMP MARKET BY TYPE

5.1. Introduction
5.2. Insulin Pump
5.3. PCA Pump
5.4. Enteral Pump
5.5. Others

6. INFUSION PUMP MARKET BY MECHANISM

6.1. Introduction
6.2. Syringe Pump
6.3. Elastomeric Pump
6.4. Peristaltic Pump
6.5. Multi-channel Pump
6.6. Smart Pump

7. INFUSION PUMP MARKET BY APPLICATION

7.1. Introduction
7.2. Chemotherapy
7.3. Gastroenterology
7.4. Diabetes
7.5. Pain Management
7.6. Hematology
7.7. Others

8. INFUSION PUMP MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Italy
- 8.4.5. Spain
- 8.4.6. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. Japan
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Taiwan
- 8.6.6. Thailand
- 8.6.7. Indonesia
- 8.6.8. Others